Agenda

< Day 1 previous page

Day 2 - 15th April

Parallel Sessions
09:00 - 10:30 10) Cancer survivorship Syndicate Room D
 

Chair – Ciarán Devane (Chief Executive, Macmillan Cancer Support)
Co-chair – Linda McCarthy (Head of Wales, Breast Cancer Care Cymru)

S28 By 2030 the number of people living with or after cancer in Wales will have doubled from 108,000 to 217,000.
Come and hear about the latest developments relating to cancer survivorship in Wales and across the UK and get
involved in a discussion about the way forward.
09:00 Cancer Survivorship in Wales
 

Ciarán Devane (Chief Executive, Macmillan Cancer Support)
09:20 The Herceptin Pathway: a non medical clinical pathway that addresses both patient and organisational needs
 

Gill Donavan (Breast Oncology Nurse Specialist, Velindre Cancer Centre)
09:40 Implementation and evaluation of an ‘After Treatment Programme’ for women following breast cancer treatment
 

Yvonne Lush (Associate Chief of Staff (Nursing), Cancer Clinical Programme Group, Betsi Cadwaladr University Health Board)
Julie A Jones (Head of Research/Clinical Audit and Effectiveness, Betsi Cadwaladr University Health Board)
10:00 Interactive workshop (30 minutes)
  This interactive workshop will give participants an opportunity to consider what needs to happen next in terms of
cancer survivorship in Wales
09:00 - 10:30 11) Young Investigator Session Assembly Room
 

Chair – Professor Jeremy Cheadle (Non-Clinical Professor of Medical Genetics, School of Medicine, Cardiff University)
Co-chair – Dr Simon Reed (Non-Clinical Reader, Department of Pathology, School of Medicine, Cardiff University)

This session will highlight some of the most significant cancer research undertaken by junior investigators
(Ph.D. students, post-doctoral scientists, M.D. students, nurses and other researchers) within Wales.
09:00 P32 Role of Polycomb Repressive Complex 2(PRC2) genes in maintaining rare chemoresistant side populations of ovarian cancer
 

Dr Sian Rizzo (Institute of Cancer Research, Surrey)

09:15 P33 Identification of human squamous cell carcinoma stem cells
 

Dr Girish Patel (Cardiff University & Cancer Institute Bethesda/Maryland)
09:30 P34 Dual inhibition of Egf and Igf-1 receptors reduces intestinal tumour burden in the Apcmin/+mouse
 

Dr Paul Shaw (Cardiff University/Velindre NHS Trust)
09:45 P35 Increased production of reactive oxygen species promotes the proliferation of human haematopoietic progenitor cells expressing activated Ras
 

Mr Paul Hole (Cardiff University)

10:00 P36 Novel protein variant of S.Pombe Rad9 acting outside of the Rad9-Rad1-Hus1 checkpoint complex in response to the anti cancer drug campothecin
 

Mr Simon Janes (School of Biological Sciences, Bangor University)

10:15 P37 Chromatin remodeling ATPase Brg-1 is an essential factor for the maintenance of the intestinal crypt stem cell and adenoma formation
 

Mr Aliaksei Holik (Cardiff University)

09:00 - 10:30 12) Immunology Syndicate Room C
 

Chair – Dr Stephen Man (Senior Lecturer, Department of Infection, Immunity and Biochemistry, School of Medicine, Cardiff University)
Co-chair – Dr Chris Pepper (Senior Lecturer, Department of Haematology, School of Medicine, Cardiff University)

09:00 S29 Cancer testis antigens and their role in immunotherapy
 

Professor Paul Moss (Head of School of Cancer Sciences and Birmingham Cancer Research UK Centre, University of Birmingham)

09:45 S30 Role of T cells in Chronic Lymphocytic Leukaemia
 

Dr Chris Pepper (Senior Lecturer, Department of Haematology, School of Medicine, Cardiff University)

10.00 S31 Novel tumour antigens
 

Dr Stephen Man (Senior Lecturer, Department of Infection, Immunity and Biochemistry, School of Medicine, Cardiff University)

10:15 S32 The role of CD200 mediated tumour immunity in Acute Myeloid Leukaemia
 

Dr Steven Coles (Research Fellow, Department of Haematology, School of Medicine, Cardiff University)

09:00 - 10:30 13) Cancer imaging:
the UK and Wales versions		 Syndicate Room B
 

Chair – Professor Malcolm Mason (CRW Professor of Clinical Oncology, Cardiff University)
Co-chair – Dr Steve Daniels (Research Director, Wales Research & Diagnostic PET Imaging Centre, Cardiff University)
09:00 S33 PET Imaging Centre in Wales
 

Dr Steve Daniels (Research Director, Wales Research & Diagnostic PET Imaging Centre, Cardiff University)
09:30 S34 Twenty years in the Frozen North: A Scottish perspective on PET
 

Professor Andy Welch (The John Mallard Scottish PET Centre, School of Medical Sciences, University of Aberdeen)
10:00 Functional imaging and radiotherapy
 

Dr Kate Newbold (Consultant Clinical Oncologist, The Royal Marsden Hospital, London)
09:00 - 10:30 14) Controversies in preventing and screening for cancers Syndicate Room L
 

Chair – Dr Hilary Fielder (Director of Screening Services, Public Health Wales)
Co-Chair - Dr Rosemary Fox (Deputy Director of Screening Services, Public Health Wales)
09:00 S35 Evaluation of birth outcomes following treatment for precancerous changes to the cervix.
 

Dr Shantini Paranjothy (Senior Clinical Lecturer, Department of Primary Care and Public Health Clinical Epidemiology, School of Medicine, Cardiff University)
09:30 S36 HPV Vaccine – did we do well?
 

Dr Richard J Roberts (Head, Vaccine Preventable Disease Programme, National Public Health Service for Wales)
10.00 S37 Evaluation of mammographic screening of very young women with raised risk of breast cancer
 

Professor Gareth Evans (Professor of Medical Genetics, Regional Genetic Service, St. Mary’s Hospital, Manchester)
10:30 – 11:00 Refreshments Marble Hall
11:00 – 11:50 Plenary session
(Sponsored by Merck Serono) 		Assembly Room
 

Merck SeronoChair – Dr Andrew Tee (Institute of Medical Genetics, Wales College of Medicine, Cardiff University)
  S38 Improper mTOR signalling and cancer: Pathway discovery identifies therapeutic targets and biomarkers
 

Professor John Blenis (Professor of Cell Biology, Harvard Medical School, Harvard University, Boston, USA)

11:50 – 12:40 Plenary session Assembly Room
  S39 Debate: Are our efforts to listen to people affected by cancer simply window dressing?
 

Chair – Penny Roberts (BBC)
Co-chair – Prof Malcolm Mason (Cancer Research Wales Professor of Clinical Oncology, Cardiff University)

 

Speaking in favour
Cath Lindley (General Manager for Wales, Macmillan Cancer Support)

 

Speaking against
Fiona Peel (Chair, Cancer Services Co-ordinating Group, Cardiff)
12:40 Closing remarks and Poster Prizes Assembly Room
 

Professor Tim Maughan (Professor of Cancer Studies, Consultant Clinical Oncologist, Velindre Hospital, Cardiff)

13:00 Close of conference  

< Day 1 previous page